IL10 and hepatocellular carcinoma: In HCC, besides IL-10 released by TAMs impairs the cytotoxicity of downstream CD8+ T cells and NK cells, increases the frequency of FOXP3+Tregs within tumours, and inhibits the activation of CD4+ CD25− T cells (24, 25).